NCT07408635 2026-02-13IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung CancerShanghai Pulmonary Hospital, Shanghai, ChinaPhase 2 Recruiting43 enrolled